Skip Navigation



IJE Advance Access published online on July 20, 2007
International Journal of Epidemiology, doi:10.1093/ije/dym137
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
37/1/36    most recent
dym137v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lund, E.
Right arrow Articles by Kumle, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lund, E.
Right arrow Articles by Kumle, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2007; all rights reserved.

Cohort Profile: The Norwegian Women and Cancer Study—NOWAC—Kvinner og kreft

Eiliv Lund1,*, Vanessa Dumeaux1,2, Tonje Braaten1, Anette Hjartåker3, Dagrun Engeset1, Guri Skeie1 and Merethe Kumle1

1Institute of Community Medicine, University of Tromsø, 9037 Tromsø, Norway.
2Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Centre, Montebello, 0310 Oslo, Norway.
3Cancer Registry of Norway, 0310 Oslo, Norway.

*Corresponding author. Institute of Community Medicine, University of Tromsø, 9037 Tromsø, Norway. E-mail: Eiliv.lund@ism.uit.no

Accepted 6 June 2007

The first 150 words of the full text of this article appear below.


   How did the study come about?
 
In the early 80s, a case-control study in California found an association between use of combined oral contraceptives (OCs) and breast cancer risk1 inducing great public concern in many countries. A group of researchers in Norway and Sweden therefore decided to conduct a population-based case-control study of OCs and breast cancer among young women.2 They found an elevated breast cancer risk for both total duration and for current OC use. However, the findings were strongly debated,3 and in several later review articles possible sources of bias in this study were proposed.4,5 Because of the potential problems of selection bias, recall bias and survivor bias with case-control studies, we decided to establish a prospective cohort study to explore the original hypothesis of use of OCs being a risk factor for breast cancer, as well as explore other risk factors for breast cancer. The data collection for the Norwegian Women and Cancer . . . [Full Text of this Article]


   What does it cover?
 
Internal validity

   Who is in the sample?
 
How often have they been followed up?
Second mailing
Third mailing
Passive follow-up by linkages
Active follow-up

   What is attrition like?
 

   What has it found?
 

   What are the main strengths and weaknesses?
 

   Can I get hold of the data? Where can I find out more?
 

   The study group
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
C. L. Parr, A. Hjartaker, P. Laake, E. Lund, and M. B. Veierod
Recall Bias in Melanoma Risk Factors and Measurement Error Effects: A Nested Case-Control Study Within the Norwegian Women and Cancer Study
Am. J. Epidemiol., February 1, 2009; 169(3): 257 - 266.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. Lund and V. Dumeaux
Systems Epidemiology in Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 2954 - 2957.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
G. Davey Smith
Big business, big science?
Int. J. Epidemiol., February 1, 2008; 37(1): 1 - 3.
[Full Text] [PDF]